Literature DB >> 15681668

Demanding pure motives for donation: the moral acceptability of blood donations by haemochromatosis patients.

G Pennings1.   

Abstract

Blood banks all over the world attempt to cover the demand for blood by donations from voluntary non-remunerated donors. The discussion regarding the acceptability of blood donations by haemochromatosis patients focuses on the question of whether health benefits violate the rule of the altruistic donor. Utilitarian and deontological arguments for and against the policy of accepting blood donors who need to let blood regularly in order to stay healthy are considered by this article. A closer look at the procedure reveals that the confusion is due to the conflation of, on the one hand the phlebotomy, and on the other hand, the decision about the destination of the blood afterwards. The health benefits are connected to the phlebotomy and not to the donation. The morally relevant point in the decision as to whether the candidate is a truly altruistic donor is whether he donates without asking for a benefit in return. It is concluded that haemochromatosis patients can be free, voluntary, and altruistic blood donors.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Year:  2005        PMID: 15681668      PMCID: PMC1734081          DOI: 10.1136/jme.2002.001271

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  18 in total

1.  Hemochromatosis and blood donors: a perspective.

Authors:  R A Sacher
Journal:  Transfusion       Date:  1999-06       Impact factor: 3.157

2.  Blood from patients with hereditary hemochromatosis--a wasted resource.

Authors:  G Jeffrey; P C Adams
Journal:  Transfusion       Date:  1999-06       Impact factor: 3.157

3.  Should we genetically test everyone for haemochromatosis?

Authors:  K Allen; R Williamson
Journal:  J Med Ethics       Date:  1999-04       Impact factor: 2.903

4.  Possible association of a reduction in cardiovascular events with blood donation.

Authors:  D G Meyers; D Strickland; P A Maloley; J K Seburg; J E Wilson; B F McManus
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

Review 5.  Monetary blood donation incentives and the risk of transfusion-transmitted infection.

Authors:  T Eastlund
Journal:  Transfusion       Date:  1998-09       Impact factor: 3.157

Review 6.  Crossover use of donated blood for autologous transfusion: report of the Council on Scientific Affairs, American Medical Association.

Authors:  L N Blum; J R Allen; M Genel; J P Howe
Journal:  Transfusion       Date:  1998-09       Impact factor: 3.157

7.  The gift of blood in Europe: an ethical defence of EC directive 89/381.

Authors:  J Keown
Journal:  J Med Ethics       Date:  1997-04       Impact factor: 2.903

8.  Screening blood donors for hereditary hemochromatosis: decision analysis model comparing genotyping to phenotyping.

Authors:  P C Adams; L S Valberg
Journal:  Am J Gastroenterol       Date:  1999-06       Impact factor: 10.864

9.  Hemochromatosis probands as blood donors.

Authors:  J C Barton; A J Grindon; N H Barton; L F Bertoli
Journal:  Transfusion       Date:  1999-06       Impact factor: 3.157

10.  A survey of phlebotomy among persons with hemochromatosis.

Authors:  S M McDonnell; A J Grindon; B L Preston; J C Barton; C Q Edwards; P C Adams
Journal:  Transfusion       Date:  1999-06       Impact factor: 3.157

View more
  3 in total

1.  What Money Cannot Buy? Compassion in Healthcare: A Response to the Recent Commentaries.

Authors:  Marianna Fotaki
Journal:  Int J Health Policy Manag       Date:  2015-10-02

2.  Evaluation of a high throughput method for the detection of mutations associated with thrombosis and hereditary hemochromatosis in Brazilian blood donors.

Authors:  Vivian Dionisio Tavares Niewiadonski; Juliana Vieira Dos Santos Bianchi; Cesar de Almeida-Neto; Nelson Gaburo; Ester Cerdeira Sabino
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

3.  Exploring the impact of terminology differences in blood and organ donor decision making.

Authors:  Stephen Whyte; Ho Fai Chan; Karin Hammarberg; Benno Torgler
Journal:  PLoS One       Date:  2020-01-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.